9 insiders reported 11 Form 4 transactions for Ovid Therapeutics Inc. (OVID) over the past 18 months (most recent 2026-07-08). Recent activity: Carter Charles Ross (Chief Financial Officer) Buy 50,000 shares, PAPADOPOULOS STELIOS (Director) Buy 17,578 shares, Friedman Bart (Director) Buy 8,789 shares, Fitzgerald Kevin Joseph (Director) Buy 17,578 shares, LEVIN JEREMY M (Executive Chairman) Buy 47,333 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-07-08 | Carter Charles Ross | Chief Financial Officer | Buy | 50,000 | $0 |
| 2026-04-09 | PAPADOPOULOS STELIOS | Director | Buy | 17,578 | $45,000 |
| 2026-04-09 | Friedman Bart | Director | Buy | 8,789 | $22,500 |
| 2026-04-09 | Fitzgerald Kevin Joseph | Director | Buy | 17,578 | $45,000 |
| 2026-03-25 | LEVIN JEREMY M | Executive Chairman | Buy | 47,333 | $66,266 |
| 2026-03-02 | ALEXANDER MARGARET A. | President and CEO | Sell | 11,656 | $16,901 |
| 2026-03-02 | Rona Jeffrey A | CBFO | Sell | 8,541 | $12,384 |
| 2026-03-02 | Rona Jeffrey A | CBFO | Buy | 68,125 | $0 |
| 2025-12-18 | LEVIN JEREMY M | CEO | Buy | 71,000 | $0 |
| 2025-12-09 | TAKEDA PHARMACEUTICAL CO LTD | Insider | Buy | 1.2M | $0 |
| 2025-12-09 | Takeda Pharmaceuticals U.S.A., Inc. | Insider | Buy | 1.2M | $0 |
Source: SEC Form 4 filings · as of 2026-07-08